Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2007
11/15/2007WO2007108744A3 Novel quinazolines as 5-ht6 modulators
11/15/2007WO2007108743A3 Novel quinazolines as 5-ht6 modulators ii
11/15/2007WO2007105233A3 An improved process for the preparation of 4,5,6-substituted 3,4-dihydropyrimidin-2-ones and their 2-thioxo analogues
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2006122319A3 Histone deacetylase inhibitors
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265444 Novel Inhibitors of Folic Acid-Dependent Enzymes
11/15/2007US20070265291 2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic acid; allergic disease; systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by itch
11/15/2007US20070265290 Male contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia; prostate cancer
11/15/2007US20070265287 Method for Producing 2-Amino-4,6-Dichloro-5-Formamidopyrimidine
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265285 Quinazolinone derivatives and their use as CB agonists
11/15/2007US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265264 Thia-tetraazaacenaphthylene kinase inhibitors
11/15/2007US20070265260 Quinazoline derivatives
11/15/2007US20070265224 Nucleotide mimics and their prodrugs
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070264600 Heterocyclic Colorants Based on Diazabenzoisoindoles
11/14/2007EP1854789A1 Quinazoline derivative having tyrosine kinase inhibitory activity
11/14/2007EP1853568A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
11/14/2007EP1853567A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
11/14/2007EP1853550A1 Indane
11/14/2007EP1853261A1 Selective inhibitors of human corticosteroid synthases
11/14/2007EP1758871B1 Pyrazolo pyrimidines
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1327629B1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses
11/14/2007CN101072781A Macrocyclic quinazoline derivatives and their use as mtki
11/14/2007CN101072779A 2,4 (4,6) pyrimidine derivatives
11/14/2007CN101072758A 喹唑啉衍生物 Quinazoline derivatives
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN101070307A 2,5,6-tri-substituted primidone derivative and medicine composition containing said derivative
11/14/2007CN100348588C Chemical synthesis method of pyrimidine thioketone
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294631 Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives
11/13/2007US7294629 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007126988A2 Selective androgen receptor modulators and methods of use thereof
11/08/2007WO2007126957A2 New compounds
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125547A2 Novel process for statins and its pharmaceutically acceptable salts thereof
11/08/2007WO2007125405A2 Substituted 2-amino-fused heterocyclic compounds
11/08/2007WO2007125351A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007WO2007076087A3 3-aryl-substituted quinazolones, and uses thereof
11/08/2007WO2007071752A3 Pyrimidinyl aryl urea derivatives being fgf inhibitors
11/08/2007WO2007031829A3 Novel pyrimidine carboxamides
11/08/2007WO2006133426A3 Compositions and methods for inhibition of the jak pathway
11/08/2007US20070260061 reacting 2-amino-3-hydroxypyridine with slight molar excess of 2-acetylbutyrolactone while azeotropically removing water, in solvent such as 4-methyl-2-pentanol, in presence of catalytic amount of acid at reflux; working up via adding alcohol and heating to reflux; crystallizing
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259894 Use of Atazanavir for Improving the Pharmacokinetics of Drugs Metabolized by Ugt1a1
11/08/2007US20070259890 Compounds and Compositions as Ppar Modulators
11/08/2007US20070259869 inhibitors of Aurora protein kinases; antiproliferative agents; melanoma, myeloma, leukemia, lymphoma, neuroblastoma, and cancer; N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-chloropyrimidin-2-ylthio)phenyl)cyclopentanecarboxamide
11/08/2007US20070259849 Azine-Carboxamides as Anti-Cancer Agents
11/08/2007US20070259823 Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
11/08/2007DE102006012251A1 Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln Substituted 4-amino-quinazoline derivatives and to their use for the preparation of medicaments
11/08/2007CA2651072A1 Substituted 2-amino-fused heterocyclic compounds
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650389A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007CA2649995A1 Amino-ethyl-amino-aryl (aeaa) compounds and their use
11/07/2007EP1852434A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
11/07/2007EP1852423A1 Crystal of 4(3h)-quinazolinone derivative
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1851206A2 Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007EP1539712B1 Pyrimidine derivatives and their use as cb2 modulators
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007EP1165523B1 Neurotrophic substituted pyrimidines
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007CN101068794A Quinazolines useful as modulators of ion channels
11/07/2007CN101068793A Potassium salt of an HIV integrase inhibitor
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066952A Crystalline pharmaceutical
11/07/2007CN100347160C Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
11/07/2007CN100346768C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
11/06/2007US7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
11/06/2007US7291730 Such as 4-chloro-6-(2-propynyloxy)pyrimidine for use as pesticide
11/06/2007US7291645 Phenylalanine derivatives as alpha 4 integrin inhibitors
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007WO2005007672A8 Small molecule toll-like receptor (tlr) antagonists
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255060 Process for the Manufacture of the Calcium Salt of Rosuvastatin (E)-7-'4-(4-Fluorophenyl)-6-Isopropyl-2-'Methyl (Methylsulfonyl) Amino ! Pyrmidin -5-Yl! (3R, 5S)-3,5-Dihydroxyhept-6-Enoic Acid and Crystalline Intermediates Thereof
11/01/2007US20070255059 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
11/01/2007US20070254902 Methods and compositions utilizing quinazolinones
11/01/2007US20070254896 Substituted pyrimidine kinase inhibitors
11/01/2007US20070254891 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidine
11/01/2007US20070254884 Compositions and Methods for Inducing Cell Dedifferentiation
11/01/2007US20070252140 Heterocyclic Radical or Diradical, the Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
10/2007
10/31/2007EP1849765A1 Method for producing pyrimidine compound
10/31/2007EP1849761A1 Process for production of 4-acetylpyrimidines and crystals thereof
10/31/2007EP1848698A2 Quinoxaline derivatives as antitumor agents
10/31/2007EP1848697A2 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 427